CropConnect 2021 Cancelled Due To COVID-19

Jul 28, 2020

The 2021 CropConnect Conference has been cancelled due to COVID-19. Below is a statement from the organizing committe:

The difficult decision has been made to cancel the 2021 CropConnect Conference, at the Victoria Inn Hotel and Convention Centre in Winnipeg due to the uncertainties regarding COVID-19 specifically relating to events of our size.

Our ag community’s well-being is our top priority. With so many unknowns the CropConnect committee felt that it was financially prudent and in everyone’s best interests that we follow the expert advice we are all receiving to limit or eliminate large group gatherings in order to continue to slow the spread of this virus in our province.

Please keep your calendars marked as planning is underway to virtually host four Annual General Meetings on February 10 & 11, 2021. Stay tuned for more details.

We appreciate your understanding and we look forward to staying connected with you and hopefully we will be back full force February 15&16, 2022.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.